ACUT - Accustem Sciences Inc.
0.2609
-0.046 -17.593%
Share volume: 1,279
Last Updated: 05-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
0.10%
PREVIOUS CLOSE
CHG
CHG%
$0.31
-0.05
-0.15%
Summary score
41%
Profitability
35%
Dept financing
50%
Liquidity
15%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-220.14%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
1223.46%
Debt ratio change over timeo
0%
Current Ratio
0.63%
Quick Ratio
0%
Cash Position Ratio
0.44%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-26.91%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
262.05%
Debt ratio change over timeo
0%
Current Ratio
0.38%
Quick Ratio
0%
Cash Position Ratio
0.01%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-25.42%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
285.03%
Debt ratio change over time
0%
Current Ratio
0.35%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACUT | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 13.23% | 9.84% | 0% |
| Return on assets | -220.14% | 4.59% | 3.2% | 0% |
| Return on sales | 0% | 30.04% | 25.15% | 0% |
| Return on invested capital | 0% | 8.51% | 10.28% | 0% |
| Profitability | 0% | 96% | 82% | 0% |
| Total debt ratio | 1223.46% | 80.7% | 59.39% | 0% |
| Debt ratio change over time | 0% | -16.59% | -73.52% | 0% |
| Dept financing | 50% | 2% | 1% | 0% |
| Current Ratio | 0.38% | 1.34% | 1.11% | 0% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0% |
| Cash Position Ratio | 0.01% | 0.14% | 0.46% | 0% |
| Liquididy | 34% | 57% | 75% | 0% |
| Short-term ratios | ACUT | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -26.91% | 5.82% | 4.08% | 0% |
| Return on sales | 0% | 38.27% | 25.36% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 0% |
| Total debt ratio | 262.05% | 81.38% | 59.57% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 8% | 6% | 0% |
| Current Ratio | 0.38% | 1.34% | 1.11% | 0% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0% |
| Cash Position Ratio | 0.01% | 0.14% | 0.46% | 0% |
| Liquididy | 7% | 58% | 66% | 0% |